Manufacturing Companies for Tofacitinib Citrate Powder - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai
Manufacturing Companies for Tofacitinib Citrate Powder - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai Detail:
Product name | Rivaroxaban |
Synonyms | 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
CAS No. | 366789-02-8 |
Appearance | White powder |
Molecular Formula | C19H18ClN3O5S |
Molecular Weight | 435.88 |
Application | Pharmaceutical grade or research purpose |
Packing | As per your request |
Storage | Preserve in tight,light-resistant containers in a cool place |
Company Information
√ Management layer’s full experience in factory and skilled technicians followers; √ Quality is always our top consideration, Strict QC system; √ 11 years experienced exporting sales team; √ Independent R&D lab; √ Two signed long term GMP workshops; √ Rich resources of plenty idle factories for customized project; √ High Efficiency working team with consistent path.Product detail pictures:
Related Product Guide:
Now we have superior devices. Our solutions are exported to your USA, the UK and so on, enjoying a superb name between customers for Manufacturing Companies for Tofacitinib Citrate Powder - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai , The product will supply to all over the world, such as: Oman, Hungary, Nepal, Our continual availability of high grade products in combination with our excellent pre-sale and after-sales service ensures strong competitiveness in an increasingly globalized market. welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!
By Phoenix from Provence - 2017.09.26 12:12
The company can keep up with the changes in this industry market, product updates fast and the price is cheap, this is our second cooperation, it's good.
By jari dedenroth from Pakistan - 2018.12.05 13:53
Write your message here and send it to us